ArticleBulletin of mathematical biology2026
Mathematical Modelling of the Mitochondrial Dicarboxylate Carrier (SLC25A10).
Article in Bulletin of mathematical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The mitochondrial dicarboxylate carrier SLC25A10 mediates reversible exchange among succinate, malate, and phosphate, contributing to mitochondrial metabolic regulation. Structural studies establish a ping-pong mechanism, but most mathematical models still assume sequential binding, lacking mechanistic justification and overlooking the alternation of a single binding site. Here, we present the first mechanistically derived and thermodynamically consistent model of SLC25A10 based on a ping-pong framework. The model incorporates competitive binding of succinate, malate, and phosphate, heteroexchange, reversibility, and electroneutrality, and is calibrated using experimental datasets from intact mitochondria and reconstituted proteoliposomes. To estimate kinetic parameters and quantify their uncertainty, we employed Bayesian inference, enabling statistically rigorous calibration to uptake and competition assays. The model introduces new terms that quantify which substrate and from which side of the membrane is most likely to start the transport cycle. Beyond reproducing experimentally observed exchange kinetics, the model resolves non-equilibrium transport dynamics that are difficult to access directly in classical uptake assays. In particular, the simulations reveal a two-phase response in which an initial phosphate-driven high-flux uptake regime for malate and succinate is followed by a slower redistribution phase in which the two dicarboxylates continue to readjust primarily against each other. The model also predicts that mitochondrial morphology modulates early transport behaviour, with matrix swelling increasing and matrix condensation decreasing the initial SLC25A10 flux magnitude. More broadly, the framework provides a quantitative basis for studying how substrate competition, thermodynamic driving forces, and compartment geometry shape SLC25A10-mediated exchange, and it offers a transferable modelling strategy for other carriers in the SLC25 family.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.